Lexaria Bioscience Corp.
LEXX
$1.35
-$0.34-20.12%
NASDAQ
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.71M | -2.70M | -2.18M | -1.78M | -649.50K |
| Total Depreciation and Amortization | 9.20K | 40.00K | 24.80K | 21.80K | 22.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 165.30K | 114.90K | 94.20K | 417.50K | 7.80K |
| Change in Net Operating Assets | 1.04M | -177.20K | 174.10K | 76.30K | -400.00 |
| Cash from Operations | -1.50M | -2.73M | -1.89M | -1.27M | -619.60K |
| Capital Expenditure | 0.00 | -24.60K | -43.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -27.90K | -13.20K | -26.60K | -22.00K | -57.00K |
| Cash from Investing | -27.90K | -37.80K | -69.60K | -22.00K | -57.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 11.70K | 4.35M | 0.00 | 5.04M | 3.45M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 11.70K | 4.35M | 0.00 | 5.04M | 3.45M |
| Foreign Exchange rate Adjustments | -95.30K | -3.20K | 2.10K | -1.20K | -25.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.61M | 1.58M | -1.96M | 3.75M | 2.75M |